275 related articles for article (PubMed ID: 3156857)
1. Tissue plasminogen activator and urokinase mediate the binding of Glu-plasminogen to plasma fibrin I. Evidence for new binding sites in plasmin-degraded fibrin I.
Harpel PC; Chang TS; Verderber E
J Biol Chem; 1985 Apr; 260(7):4432-40. PubMed ID: 3156857
[TBL] [Abstract][Full Text] [Related]
2. Sequence of formation of molecular forms of plasminogen and plasmin-inhibitor complexes in plasma activated by urokinase or tissue-type plasminogen activator.
Thorsen S; Müllertz S; Suenson E; Kok P
Biochem J; 1984 Oct; 223(1):179-87. PubMed ID: 6208894
[TBL] [Abstract][Full Text] [Related]
3. Initial plasmin-degradation of fibrin as the basis of a positive feed-back mechanism in fibrinolysis.
Suenson E; Lützen O; Thorsen S
Eur J Biochem; 1984 May; 140(3):513-22. PubMed ID: 6233145
[TBL] [Abstract][Full Text] [Related]
4. Interactions between staphylokinase, plasmin(ogen), and fibrin. Staphylokinase discriminates between free plasminogen and plasminogen bound to partially degraded fibrin.
Sakharov DV; Lijnen HR; Rijken DC
J Biol Chem; 1996 Nov; 271(44):27912-8. PubMed ID: 8910391
[TBL] [Abstract][Full Text] [Related]
5. Tissue plasminogen activator and urokinase enhance the binding of plasminogen to thrombospondin.
Silverstein RL; Harpel PC; Nachman RL
J Biol Chem; 1986 Jul; 261(21):9959-65. PubMed ID: 2942536
[TBL] [Abstract][Full Text] [Related]
6. The mechanism of activation of plasminogen at the fibrin surface by tissue-type plasminogen activator in a plasma milieu in vitro. Role of alpha 2-antiplasmin.
Rouy D; Anglés-Cano E
Biochem J; 1990 Oct; 271(1):51-7. PubMed ID: 1699517
[TBL] [Abstract][Full Text] [Related]
7. Activation of plasminogen by pro-urokinase. I. Mechanism.
Lijnen HR; Zamarron C; Blaber M; Winkler ME; Collen D
J Biol Chem; 1986 Jan; 261(3):1253-8. PubMed ID: 2935528
[TBL] [Abstract][Full Text] [Related]
8. Tissue-type plasminogen activator increases the binding of glu-plasminogen to clots.
Tran-Thang C; Kruithof EK; Bachmann F
J Clin Invest; 1984 Dec; 74(6):2009-16. PubMed ID: 6210307
[TBL] [Abstract][Full Text] [Related]
9. Different molecular forms of plasminogen and plasmin produced by urokinase in human plasma and their relation to protease inhibitors and lysis of fibrinogen and fibrin.
Müllertz S
Biochem J; 1974 Nov; 143(2):273-83. PubMed ID: 4282470
[TBL] [Abstract][Full Text] [Related]
10. Activation pathway of glu-plasminogen to Lys-plasmin by urokinase.
Takada A; Takada Y
Thromb Res; 1982 Sep; 27(6):671-7. PubMed ID: 6129717
[TBL] [Abstract][Full Text] [Related]
11. Tissue-type plasminogen activator and its substrate Glu-plasminogen share common binding sites in limited plasmin-digested fibrin.
de Vries C; Veerman H; Koornneef E; Pannekoek H
J Biol Chem; 1990 Aug; 265(23):13547-52. PubMed ID: 2143185
[TBL] [Abstract][Full Text] [Related]
12. The effects of fibrinogen and its cleavage products on the kinetics of plasminogen activation by urokinase and subsequent plasmin activity.
Lucas MA; Straight DL; Fretto LJ; McKee PA
J Biol Chem; 1983 Oct; 258(20):12171-7. PubMed ID: 6226655
[TBL] [Abstract][Full Text] [Related]
13. Identification of molecular forms of plasminogen and plasmin-inhibitor complexes in urokinase-activated human plasma.
Müllertz S; Thorsen S; Sottrup-Jensen L
Biochem J; 1984 Oct; 223(1):169-77. PubMed ID: 6208893
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a recombinant chimeric plasminogen activator with enhanced fibrin binding.
Jiao J; Yu M; Ru B
Biochim Biophys Acta; 2001 Apr; 1546(2):399-405. PubMed ID: 11295444
[TBL] [Abstract][Full Text] [Related]
15. Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained.
Pannell R; Black J; Gurewich V
J Clin Invest; 1988 Mar; 81(3):853-9. PubMed ID: 2963831
[TBL] [Abstract][Full Text] [Related]
16. High-affinity binding sites for human Glu-plasminogen unveiled by limited plasmic degradation of human fibrin.
Tran-Thang C; Kruithof EK; Atkinson J; Bachmann F
Eur J Biochem; 1986 Nov; 160(3):599-604. PubMed ID: 2946579
[TBL] [Abstract][Full Text] [Related]
17. Interaction of heparin with plasminogen activators and plasminogen: effects on the activation of plasminogen.
Andrade-Gordon P; Strickland S
Biochemistry; 1986 Jul; 25(14):4033-40. PubMed ID: 2943315
[TBL] [Abstract][Full Text] [Related]
18. A monoclonal antibody specific for two-chain urokinase-type plasminogen activator. Application to the study of the mechanism of clot lysis with single-chain urokinase-type plasminogen activator in plasma.
Declerck PJ; Lijnen HR; Verstreken M; Moreau H; Collen D
Blood; 1990 May; 75(9):1794-800. PubMed ID: 1691934
[TBL] [Abstract][Full Text] [Related]
19. Actin stimulates plasmin generation by tissue and urokinase-type plasminogen activators.
Lind SE; Smith CJ
Arch Biochem Biophys; 1993 Nov; 307(1):138-45. PubMed ID: 8239651
[TBL] [Abstract][Full Text] [Related]
20. Tissue plasminogen activator (tPA) inhibits plasmin degradation of fibrin. A mechanism that slows tPA-mediated fibrinolysis but does not require alpha 2-antiplasmin or leakage of intrinsic plasminogen.
Wu JH; Diamond SL
J Clin Invest; 1995 Jun; 95(6):2483-90. PubMed ID: 7769094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
